Mint Tower Capital Management’s Gilead Sciences GILD Stock Holding History

Mint Tower Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,000	Closed	-$2.15M	–	316
2022 Q4	$2.15M	Sell	25,000 -25,000	-50%	-$1.98M	0.19%	96
2022 Q3	$3.08M	Buy	50,000 +12,100	+32%	+$763K	0.24%	89
2022 Q2	$2.34M	Sell	37,900 -10,100	-21%	-$625K	0.19%	106
2022 Q1	$2.85M	Buy	48,000 +46,000	+2,300%	+$2.94M	0.26%	68
2021 Q4	$145K	Buy	+2,000	New	+$138K	0.02%	293
2020 Q1	–	Sell	-103,100	Closed	-$6.7M	–	250
2019 Q4	$6.7M	Sell	103,100 -23,000	-18%	-$1.5M	0.89%	27
2019 Q3	$7.99M	Buy	126,100 +20,300	+19%	+$1.33M	1.16%	12
2019 Q2	$7.15M	Sell	105,800 -29,700	-22%	-$1.95M	0.78%	22
2019 Q1	$8.81M	Buy	135,500 +135,427	+185,516%	+$9M	0.85%	18
2018 Q4	$457K	Sell	73 -74,927	-100%	-$5.24M	0.06%	142
2018 Q3	$5.79M	Sell	75,000 -15,000	-17%	-$1.13M	0.72%	25
2018 Q2	$6.38M	Sell	90,000 -25,000	-22%	-$1.77M	0.85%	25
2018 Q1	$8.67M	Buy	115,000 +114,825	+65,614%	+$9.13M	1.16%	12
2017 Q4	$1.25M	Buy	+175	New	+$13.3K	0.19%	69

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mint Tower Capital Management's GILD Position: Q1 2023 in Review

Mint Tower Capital Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 5,004 shares — an estimated $430K sold.

Mint Tower Capital Management first reported a position in GILD in Q4 2017 and held it in 7 quarters. The position peaked at $2.19M in Q4 2019. 1,736 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Mint Tower Capital Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
Mint Tower Capital Management sold 5,004 Gilead Sciences shares in Q1 2023, an estimated $430K.
Mint Tower Capital Management first reported a position in Gilead Sciences in Q4 2017 and held it in 7 quarters.
Mint Tower Capital Management's Gilead Sciences position peaked at $2.19M in Q4 2019.
1,736 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Mint Tower Capital Management's 13F filing for Q1 2023, filed 9 May 2023.